3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Squamous Cell Carcinoma of Head and Neck
5
Endometrial Neoplasms
5
Neoplasms
4
Head and Neck Neoplasms
3
Breast Neoplasms
3
Rectal Neoplasms
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Small Cell Lung Carcinoma
1
Skin Neoplasms
1
Pathologic Complete Response
1
Ovarian Neoplasms
1
Ovarian Carcinosarcoma
1
Oropharyngeal Neoplasms
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Mouth Neoplasms
1
Lung Neoplasms
1
Laryngeal Diseases
1
Hemangiosarcoma
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Squamous Cell
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Neuroendocrine
1
Interventions
Vincristine
8
X-Rays
6
Temozolomide
6
Phantoms, Imaging
6
Magnetic Resonance Spectroscopy
6
Cyclophosphamide
6
Specimen Handling
5
Irinotecan
5
Nuclear Medicine Department, Hospital
4
Biopsy
4
Radiotherapy
3
Radiation
3
Dactinomycin
3
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
palbociclib
2
larotrectinib
2
ivosidenib
2
fludarabine
2
ensartinib
2
Vinorelbine
2
Proton Therapy
2
LY3023414
2
Ifosfamide
2
Filgrastim
2
Etoposide
2
Doxorubicin
2
Dexrazoxane
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Rhabdomyosarcoma
×
dostarlimab
×
90 days
×
Clear all
No trials found.